As a medium, the Internet neither helps nor harms in multiple sclerosis care - what matters is how clinicians and patients engage in that medium, according to Paul Wicks, PhD, vice president of innovation at PatientsLikeMe.
As a medium, the internet neither helps nor harms in multiple sclerosis (MS) care — what matters is how clinicians and patients engage in that medium, according to Paul Wicks, PhD, vice president of innovation at PatientsLikeMe.
His company is a Patient Powered Research Network, which are becoming increasingly common, he explained during his session at the 2014 ACTRIMS-ECTRIMS Joint Meeting in Boston, Massachusetts.
“What [these networks] signify is a move from the internet being full of stories to being full of data,” he explained.
What percentage of all MS patients are actually listened to and taken seriously, Wicks wondered. How much real-time data is being tracked on these individuals? If a smartphone app like Angry Birds or Candy Crush crashes, a bug report is immediately sent to the developer to help prevent the issue from happening again, and Wicks asserted that this system is better than the one in place in healthcare.
“We have better data tracking systems for our video games than for our patients,” he said.
One of the areas that PatientsLikeMe believes getting patient input is important is with patient-reported outcomes. By listening to what they have to say in this area, clinicians can be sure they are measuring things that are important to patients and ensure individuals are no longer just telling stories, but delivering quantifiable data that can be used.
Similar to a social network, users on PatientLikeMe share data about symptom onset, type of condition, and experience with different disease-modifying therapies. The purpose is not to give recommendations to other patients, but for the data from each individual experience to be aggregated and used to the best advantage.
To keep out the so-called “quacks” and frauds, Wicks explained that PatientsLikeMe uses computer security methods to prevent people from logging in with multiple accounts and spamming the site, and relies on the community to flag inappropriate posts. Plus, trained moderators, some of whom are nurses, ensure there is no bullying taking place.
He beseeched people to keep an open mind about the data being shared, although be “not so open minded that our brains fall out.”
“Increasingly, the internet, with its culture of open and sharing, is coming to infect medicine and it’s time we took that and got used to it,” he said.
Pegcetacoplan for PNH More Cost-Effective Than Anti-C5 Monoclonal Antibodies
April 18th 2024A cost-utility analysis conducted from the perspective of the Italian health system found that pegcetacoplan was more effective and less costly than 2 complement 5 (C5) inhibitors for the treatment of paroxysmal nocturnal hemoglobinuria (PNH).
Read More
Collecting SDOH Data Can Assess Risk of Medical Nonadherence, Improve HEI and Star Ratings
April 18th 2024At the Academy of Managed Care Pharmacy (AMCP) 2024 annual meeting, a panel of presenters explored changes coming to Medicare that incorporate social determinants of health (SDOH) data to improve patient and health system outcomes.
Read More
Commonwealth Fund Report Details Pervasive Racial and Ethnic Disparities in US Health Care, Outcomes
April 18th 2024Using 25 health system performance indicators, the Commonwealth Fund 2024 State Health Disparities Report evaluated racial and ethnic disparities in health care and health outcomes both within and across US states and highlighted the urgent need for equitable health care policies and practices in the US.
Read More
Survival Rates in CLL: Targeted Agents vs Fludarabine Combo Therapy Study
April 17th 2024Researchers conducted an analysis of 4 phase 3 trials, covering 2751 patients, to address the potential for targeted agents in younger and physically fit patients who have chronic lymphocytic leukemia (CLL).
Read More